Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses.
Maldonado S, Fuentes P, Bernabeu E, Bertera F, Opezzo J, Lagomarsino E, Lee HJ, Martínez Rodríguez F, Choi MR, Salgueiro MJ, Damonte EB, Höcht C, Moretton MA, Sepúlveda CS, Chiappetta DA.
Maldonado S, et al. Among authors: sepulveda cs.
Pharmaceutics. 2025 Feb 12;17(2):241. doi: 10.3390/pharmaceutics17020241.
Pharmaceutics. 2025.
PMID: 40006610
Free PMC article.